Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofIrinotecan Hydrochloride Injectionfrom Surat, Gujarat, India. Irinotecan Hydrochloride Injection used to treat colon cancer, and small cell lung cancer.For colon cancer it is used either alone or with fluorouracil.
Tags: Irinotecan Hydrochloride Injection manufacturer, Irinotecan HydrochlorideInjection exporter, Irinotecan Hydrochloride Injection supplier,and Irinotecan Hydrochloride Injection, whogmp approved Irinotecan HydrochlorideInjection manufacturer and supplier, Irinotecan Hydrochloride Injectiondistributor, Irinotecan Hydrochloride Injection shipper, Irinotecan HydrochlorideInjection 15 ml Irinotecan Hydrochloride Injection 15 mlsupplier,Irinotecan Hydrochloride Injection 15 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy Lifescience Irinotecan HydrochlorideInjection export to USA, Canada, Germany, Europe, France, Ghana,Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru,Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia,Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Trusted Oncology SupportIrinotecan Hydrochloride Injection offers targeted therapy for patients facing metastatic colorectal and small cell lung cancers. With regulatory approvals from the US FDA, EMA, and Indian authorities, it assures compliance and quality. This product is accessible through dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India, ensuring reliable supply and patient access.
Reliable Formulation and AdministrationEach glass vial contains a sterile, clear to pale yellow solution designed specifically for intravenous infusion. The product displays excellent compatibility with standard intravenous fluids, making it straightforward for healthcare professionals to integrate into oncology treatment protocols. Its odorless and stable nature ensures both patient and provider ease of use.
FAQ's of Irinotecan Hydrochloride Injection:
Q: How is Irinotecan Hydrochloride Injection administered to patients?
A: This medication is designed for intravenous infusion and must be administered by qualified healthcare professionals under the supervision of an oncologist. The dosage and infusion rate are determined based on the patient's condition and medical history.
Q: What is the recommended storage process for Irinotecan Hydrochloride Injection?
A: The injection should be stored in a cool and dry place, away from direct light and heat. Adhering to these storage guidelines helps preserve the vial's stability and maintains its effectiveness throughout its two-year shelf life.
Q: When is Irinotecan Hydrochloride Injection indicated for use?
A: It is indicated for the treatment of metastatic colorectal cancer, small cell lung cancer, and various other solid tumors where Irinotecan is part of the recommended treatment protocol.
Q: Where can I obtain Irinotecan Hydrochloride Injection in India?
A: This product is distributed widely in India through authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers. A valid medical prescription is required to purchase and use this medication.
Q: What are the key usage benefits of Irinotecan Hydrochloride Injection?
A: Its principal benefit lies in its proven efficacy as part of chemotherapy regimens for certain advanced cancers, offering patients improved management and potential outcomes. Its stability, compatibility with standard fluids, and clear dosing guidelines add further clinical value.
Q: What precautions should be taken before starting treatment with this injection?
A: Patients should only receive Irinotecan Hydrochloride Injection under the care of a qualified oncologist. It is contraindicated for those with known hypersensitivity to Irinotecan or any of its excipients. Regular monitoring during treatment is crucial to manage potential side effects.